Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciae359 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Félix Gutiérrez und 30 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain. Hauptthemen laut MEDLINE: HIV Infections, Early Detection of Cancer, Precancerous Conditions, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish National Plan for Scientific and Technical Research and Innovation, Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fondo Europeo de Desarrollo Regional.
Abstract (Originalsprache)
Background
Non-AIDS defining malignancies present a growing challenge for persons with human immunodeficiency virus (HIV, PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was designed to compare two comprehensive cancer screening strategies integrated into routine HIV care. This study reports baseline data on the prevalence and types of precancerous lesions and early-stage cancer among participants at enrolment. Acceptability of the procedure was additionally assessed.
Methods
Cross-sectional analysis of a comprehensive screening protocol to detect precancer and cancer. The readiness of healthcare providers to implement the protocol was evaluated using a validated 4-item survey.
Results
Among the 1430 enrolled PWH, 1172 underwent 3181 screening tests, with positive findings in 29.4% of cases, leading to further investigation in 20.7%. Adherence to the protocol was 84%, with HIV providers expressing high acceptability (97.1%), appropriateness (91.4%), and feasibility (77.1%). A total of 145 lesions were identified in 109 participants, including 60 precancerous lesions in 35 patients (3.0%), 9 early-stage cancers in 9 patients (0.8%), and 76 low-risk lesions in 65 subjects (5.5%). Adverse events related to screening occurred in 0.8% of participants, all mild. The overall prevalence of cancer precursors or early-stage cancer was 3.8% (95% confidence interval [CI], 2.74%–5.01%), with highest rates observed in individuals screened for anal and colorectal cancers.
Conclusions
The baseline comprehensive cancer screening protocol of the IMPAC-Neo study successfully identified a significant proportion of PWH with precancerous lesions and early-stage cancer. High adherence rates and positive feedback from providers suggest effective implementation potential in real-world healthcare settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain.
- Clinical Medicine Department, Universidad Miguel Hernández, San Juan de Alicante, Spain.
- CIBERINFEC, Madrid, Spain.
- HIV and STI Unit-Service of Internal Medicine, Hospital Universitario Virgen de la Arrixaca and Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
- Department of Infectious Diseases, Hospital Universitari de Bellvitge, L´Hospitalet de Llobregat, Spain.
- Infectious Diseases Unit, Hospital Universitario de Araba, Vitoria-Gasteiz, Spain.
ORCID-Profile: Félix Gutiérrez, Leandro López, Juan Manuel Tiraboschi, Lucio García-Fraile, Enrique Bernal, Antonio Rivero, Javier García-Abellán, Ana González-Cordón, Joaquín Bravo, Marta Montero, Miguel Torralba, Juan Macías, Inmaculada Gónzalez-Cuello, Vicente Boix, Paula Dios, Jose Ramón Blanco, Sergio Padilla, Marta Fernández-González, Ana Gutiérrez-Ortiz de la Tabla, Mar Masiá
Förderung
- Spanish National Plan for Scientific and Technical Research and Innovation
- Instituto de Salud Carlos III
- Subdireccion General de Evaluacion y Fondo Europeo de Desarrollo Regional
Zitieren
APA
Gutiérrez, F., López, L., Galera, C., Tiraboschi, J. M., Portu, J., García-Fraile, L., García Del Toro, M., Bernal, E., Rivero, A., García-Abellán, J., Flores, J., González-Cordón, A., Martínez, O., Bravo, J., Rosado, D., Montero, M., Sirera, G., Torralba, M., Galindo, M. J., …, & IMPAC-Neo Study Group (2025). Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae359
Vancouver
Gutiérrez F, López L, Galera C, Tiraboschi JM, Portu J, García-Fraile L, et al. Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae359
BibTeX
@article{Gutirrez2025,
author = {Gutiérrez, Félix and López, Leandro and Galera, Carlos and Tiraboschi, Juan Manuel and Portu, Joseba and García-Fraile, Lucio and García Del Toro, Miguel and Bernal, Enrique and Rivero, Antonio and García-Abellán, Javier and Flores, Juan and González-Cordón, Ana and Martínez, Onofre and Bravo, Joaquín and Rosado, Dácil and Montero, Marta and Sirera, Guillem and Torralba, Miguel and Galindo, Maria José and Macías, Juan and Gónzalez-Cuello, Inmaculada and Boix, Vicente and Vivancos, María Jesús and Dios, Paula and Blanco, Jose Ramón and Padilla, Sergio and Fernández-González, Marta and Gutiérrez-Ortiz de la Tabla, Ana and Martínez, Esteban and Masiá, Mar and IMPAC-Neo Study Group, IMPAC-Neo Study Group},
title = {Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciae359}
}
EUVIMED